Free CTC to in-hand salary calculator for FY 2026-27: monthly take-home under the new and old tax regimes, with PF, gratuity, professional tax and the 50% wage rule.

The coin-sized device can detect circulating cancer cells (CTCs) that break away from a tumor and travel through the bloodstream, potentially causing metastases.

CelLBxHealth (AIM:CLBX), the AIM-listed developer of the Parsortix microfluidic platform for capturing circulating tumour cells (CTCs), said it has signed a…

Circulating tumor cell (CTC) clusters are potent drivers of metastasis, exhibiting markedly greater metastatic capacity than single CTCs. Beyond homotypic CTC clusters, CTCs dynamically engage immune cells to form heterotypic clusters with enhanced metastatic fitness. Rather than passive assemblies, these clusters function as coordinated metastatic ecosystems, integrating adhesion, immune modulation, and metabolic adaptation to promote survival, plasticity, and immune evasion. Recent advances in CTC isolation, single-cell and spatial multiomics, and artificial intelligence-driven analyses have enabled unprecedented resolution of these dynamic interactions. Together, these findings support a conceptual shift from isolated single-cell dissemination to multicellular cooperation as an important principle of metastasis and identify CTC–immune cell clusters as actionable targets for next-generation therapies to boost immunity and prevent metastasis.

SignificanceDiffuse in vivo flow cytometry (DiFC) is an emerging technique for enumerating rare, fluorescently labeled circulating tumor cells (CTCs) in small animals without drawing blood samples. Di